CNBX Pharmaceuticals (8C80) Financial Statements
CNBX Pharmaceuticals Financial Overview
CNBX Pharmaceuticals's market cap is currently $286.60K. The company's EPS TTM is $0.00; its P/E ratio is -0.50; CNBX Pharmaceuticals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Aug 25 | Aug 24 | Aug 23 | Aug 22 | Aug 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 130.07K | $ 410.17K | $ 29.96K | $ 0.00 |
| Gross Profit | $ 0.00 | $ 130.07K | $ 410.17K | $ -169.00K | $ -221.00K |
| Operating Income | $ -271.69K | $ -583.00K | $ -931.00K | $ -2.95M | $ -2.60M |
| EBITDA | $ -273.79K | $ -603.00K | $ -3.55M | $ -3.52M | $ -2.91M |
| Net Income | $ -313.98K | $ -695.00K | $ -3.71M | $ -3.72M | $ -3.19M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 15.11K | $ 26.42K | $ 129.70K | $ 117.52K | $ 1.39M |
| Total Assets | $ 18.44K | $ 31.38K | $ 499.04K | $ 811.17K | $ 3.08M |
| Total Debt | $ 1.20M | $ 1.30M | $ 1.34M | $ 1.76M | $ 871.90K |
| Net Debt | $ 1.18M | $ 1.27M | $ 1.21M | $ 1.64M | $ -514.58K |
| Total Liabilities | $ 2.51M | $ 2.51M | $ 2.52M | $ 2.44M | $ 1.27M |
| Stockholders' Equity | $ -2.50M | $ -2.48M | $ -2.02M | $ -1.63M | $ 1.81M |
| Cash Flow | |||||
| Free Cash Flow | $ -171.31K | $ -245.47K | $ -112.52K | $ -1.68M | $ -2.49M |
| Operating Cash Flow | $ -171.31K | $ -244.27K | $ -112.52K | $ -1.68M | $ -2.49M |
| Investing Cash Flow | $ 0.00 | $ 113.48K | $ 24.70K | $ 25.23K | $ 645.02K |
| Financing Cash Flow | $ 160.00K | $ 27.51K | $ 100.00K | $ 389.86K | $ 2.46M |
Currency in USD